European Union: Boost for AIDS Pill

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

U.S. Centers for Disease Control and Prevention • International News

European Union: Boost for AIDS Pill

January 31, 2008

Illinois-based Abbott Laboratories reports it has won a European regulatory advisory committee's endorsement of the pediatric formulation of its AIDS drug Kaletra. The approval means the child-size dose could be available for sale in Europe in 60 to 90 days. European clearance of a drug typically leads to approval in developing nations as well. Kaletra is known in some countries as Aluvia.

Back to other news for January 2008

Search the Newsroom archive

Excerpted from:
Chicago Tribune
01.31.2008; Bruce Japsen

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.